Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT01654965 · COMPLETED
Trial details
- NCT number
- NCT01654965
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-24
- Primary completion
- 2018-03-29
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.